|
Volumn 13, Issue 1, 2010, Pages 1-5
|
Why has MRSA become such a successful pathogen? A pediatric perspective
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
DAPTOMYCIN;
GENTAMICIN;
NAFCILLIN;
OXACILLIN;
PANTON VALENTINE LEUKOCIDIN;
PENICILLIN G;
TIGECYCLINE;
VANCOMYCIN;
ABSCESS;
BACTERIAL ARTHRITIS;
BACTERIUM CULTURE;
BACTERIUM ISOLATE;
BLOOD CULTURE;
CELLULITIS;
COMMUNICABLE DISEASE;
DEEP VEIN THROMBOSIS;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
EPIDEMIC;
FULMINATING PURPURA;
HUMAN;
INFANT MORTALITY;
INFECTION COMPLICATION;
INFECTION RISK;
INTENSIVE CARE;
LOADING DRUG DOSE;
LUNG EMBOLISM;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION;
NECROTIZING PNEUMONIA;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
ONSET AGE;
OSTEOMYELITIS;
PATHOGENESIS;
PHYSICAL EXAMINATION;
PNEUMONIA;
PYOMYOSITIS;
SEPTICEMIA;
SEX DIFFERENCE;
SHORT SURVEY;
SURGICAL TECHNIQUE;
TREATMENT DURATION;
|
EID: 79953807680
PISSN: None
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (1)
|
References (7)
|